Home › Funds › Affinity Asset Advisors, LLC › COGT
Affinity Asset Advisors, LLC position in COGT
COGENT BIOSCIENCES INC · Health Care
Affinity Asset Advisors, LLC reported holding 11,000,000 shares of COGT (COGENT BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$12.1M, representing 0.56% of its reported portfolio and ranking #42 among its reported holdings. Affinity Asset Advisors, LLC has disclosed COGT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Affinity Asset Advisors, LLC's COGT position evolved
Affinity Asset Advisors, LLC first disclosed a stake in COGT in Q4 2025 at 1,000,000 shares (US$1.2M). The position peaked in Q2 2026 at 11,000,000 shares, worth US$13.7M. Across 4 filings, Affinity Asset Advisors, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 11,000,000 shares valued at US$12.1M. Notable position changes include a 600% increase in Q1 2026 (shares were roughly flat over the following quarter), a 57% increase in Q2 2026 (shares fell 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.00M | $1.18M | New |
| Q1 2026 | 7.00M | $8.59M | Add |
| Q2 2026 | 11.00M | $13.65M | Add |
| Q3 2026 | 11.00M | $12.05M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About COGT and 13F data
COGT (COGENT BIOSCIENCES INC) is a Health Care company. 54 other funds we track also report a position in COGT — the largest reported positions include Fairmount Funds Management LLC (US$213.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$193.7M), TCG Crossover Management, LLC (US$187.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COGT
- Fairmount Funds Management LLC 5.50M sh · $212.98M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 5.01M sh · $193.74M · Q2 2026
- TCG Crossover Management, LLC 4.85M sh · $187.87M · Q2 2026
- Kynam Capital Management, LP 3.67M sh · $141.92M · Q2 2026
- Commodore Capital LP 3.05M sh · $118.03M · Q2 2026
- Octagon Capital Advisors LP 2.35M sh · $90.94M · Q2 2026
- RTW INVESTMENTS, LP 2.31M sh · $89.36M · Q2 2026
- Deep Track Capital, LP 2.00M sh · $77.40M · Q2 2026
- Venrock Adviser, LLC 1.64M sh · $63.55M · Q2 2026
- EMERALD ADVISERS, LLC 1.61M sh · $51.67M · Q3 2026
- Siren, L.L.C. 1.61M sh · $51.53M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.57M sh · $50.42M · Q3 2026
More on Affinity Asset Advisors, LLC
FAQ
How long has Affinity Asset Advisors, LLC held COGT?
Affinity Asset Advisors, LLC has disclosed COGT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Affinity Asset Advisors, LLC's current position in COGT?
As of Q3 2026, Affinity Asset Advisors, LLC holds 11.00M shares of COGT (COGENT BIOSCIENCES INC), valued at $12.05M, representing 0.56% of its reported portfolio and ranking #42.
Has Affinity Asset Advisors, LLC been buying or selling COGT?
In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC held unchanged its position in COGT. The position peaked in Q2 2026 at 11.00M shares.
Which other funds hold COGT?
Other major institutional holders of COGT include Fairmount Funds Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P., TCG Crossover Management, LLC, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.